Cronos Group Inc. (TSE:CRON – Get Free Report)’s stock price was up 1.6% during trading on Tuesday . The stock traded as high as C$3.85 and last traded at C$3.81. Approximately 88,037 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 177,427 shares. The stock had previously closed at C$3.75.
Analysts Set New Price Targets
Separately, TD increased their target price on shares of Cronos Group from C$4.50 to C$5.50 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Cronos Group currently has an average rating of “Buy” and a consensus target price of C$4.75.
Get Our Latest Stock Report on CRON
Cronos Group Stock Up 0.3%
Cronos Group (TSE:CRON – Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported C$0.06 EPS for the quarter. Cronos Group had a negative return on equity of 0.19% and a negative net margin of 1.29%.The company had revenue of C$62.86 million for the quarter. On average, analysts anticipate that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.
Cronos Group Company Profile
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.
Read More
- Five stocks we like better than Cronos Group
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
